Frank Rimerman Advisors LLC purchased a new position in shares of Markel Group Inc. (NYSE:MKL – Free Report) during the second quarter, Holdings Channel reports. The institutional investor purchased 200 shares of the insurance provider’s stock, valued at approximately $315,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Gilbert & Cook Inc. boosted its holdings in shares of Markel Group by 5.6% in the 4th quarter. Gilbert & Cook Inc. now owns 529 shares of the insurance provider’s stock worth $751,000 after buying an additional 28 shares during the last quarter. Commerce Bank boosted its stake in Markel Group by 108.9% in the fourth quarter. Commerce Bank now owns 1,356 shares of the insurance provider’s stock valued at $1,925,000 after acquiring an additional 707 shares during the last quarter. Hsbc Holdings PLC grew its position in shares of Markel Group by 10.5% during the 4th quarter. Hsbc Holdings PLC now owns 14,558 shares of the insurance provider’s stock valued at $20,679,000 after acquiring an additional 1,389 shares during the period. Hilltop Holdings Inc. raised its holdings in shares of Markel Group by 5.9% in the 4th quarter. Hilltop Holdings Inc. now owns 216 shares of the insurance provider’s stock worth $307,000 after purchasing an additional 12 shares during the period. Finally, Steward Partners Investment Advisory LLC lifted its stake in Markel Group by 50.3% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 451 shares of the insurance provider’s stock valued at $640,000 after purchasing an additional 151 shares during the last quarter. Hedge funds and other institutional investors own 77.12% of the company’s stock.
Markel Group Price Performance
Shares of NYSE MKL opened at $1,572.16 on Wednesday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.60 and a current ratio of 0.60. Markel Group Inc. has a fifty-two week low of $1,295.65 and a fifty-two week high of $1,670.24. The stock has a market cap of $20.44 billion, a PE ratio of 8.49 and a beta of 0.73. The stock has a fifty day moving average of $1,564.50 and a 200-day moving average of $1,554.66.
Analyst Upgrades and Downgrades
MKL has been the subject of a number of recent research reports. Citigroup raised their target price on Markel Group from $1,435.00 to $1,450.00 and gave the stock a “sell” rating in a research report on Tuesday, July 23rd. TD Cowen initiated coverage on Markel Group in a report on Tuesday, July 9th. They issued a “buy” rating and a $1,986.00 price objective for the company. One analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $1,626.83.
Check Out Our Latest Stock Analysis on MKL
Insiders Place Their Bets
In other news, Director Lawrence A. Cunningham purchased 20 shares of the firm’s stock in a transaction dated Monday, August 5th. The shares were purchased at an average price of $1,512.50 per share, with a total value of $30,250.00. Following the completion of the acquisition, the director now owns 743 shares in the company, valued at approximately $1,123,787.50. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 1.71% of the company’s stock.
Markel Group Company Profile
Markel Group Inc, a diverse holding company, engages in marketing and underwriting specialty insurance products in the United States, Bermuda, the United Kingdom, and Germany. The company offers general and professional liability, personal lines, marine and energy, specialty programs, and workers' compensation insurance products; and property coverages that include fire, allied lines, and other specialized property coverages, including catastrophe-exposed property risks, such as earthquake and wind.
Further Reading
- Five stocks we like better than Markel Group
- Are Penny Stocks a Good Fit for Your Portfolio?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Quiet Period Expirations Explained
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Want to see what other hedge funds are holding MKL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Markel Group Inc. (NYSE:MKL – Free Report).
Receive News & Ratings for Markel Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel Group and related companies with MarketBeat.com's FREE daily email newsletter.